ADVM-022 (Ixoberogene Soroparvovec) (Intravitreal Injection)
ADVM-022 (Ixoberogene Soroparvovec) is an investigational gene therapy being studied for the treatment of Wet Age-related Macular Degeneration (Wet AMD). Drug class Gene Therapy Type Single Forms Intravitreal Injection Common strength Per dose Prescription status Investigational What ADVM-022 (Ixoberogene Soroparvovec) is used for ADVM-022 (Ixoberogene Soroparvovec) is an investigational medicine currently being studied for the
